TheStreet.com

Johnson & Johnson Joins the Breakup Club: Here’s How to Play It

Just days after industrial conglomerate General Electric announced that firm’s future de-conglomerization, and less recently after fellow pharmaceutical giants Pfizer and Merck had spun out their respective consumer businesses, comes the next shoe to drop. Johnson & Johnson , the world’s largest health products company by sales and employer of more than 136K human beings, announced that the longstanding member of the Dow Jones Industrial Average will be separating into two distinct firms, but not right away. A push to simplify business direction in order to improve focus during complex times?